Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%

Clinical trial NCT04986202 · COMPLETED

Trial details

NCT number: NCT04986202
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Heart Failure With Preserved Ejection Fraction

Start date: 2021-06-30
Primary completion: 2024-03-27
Enrollment: 711

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.